Screening for lung cancer
127 results
74 - 127
Italian lung cancer screening findings consistent with US National Lung Screening Trial results (ITALUNG)- After community lung cancer screening, rates of follow-up imaging are lower but the rates of some procedures are higher
- Annual screening chest x-ray does not reduce lung cancer mortality
- USPSTF 2021 recommends annual lung cancer screening based on shared decision-making in high-risk adults (B recommendation)
Population screening for cancer - High false-positive rate with lung cancer screening
- Lung cancer screening is cost effective, but only if done correctly
- Spiral CT detects early lung cancer, but screening use is premature
- One in five patients overdiagnosed with lung CA screening
- Lung cancer is infrequently found via screening, but follow-up imaging is common
- Lung cancers
- Screening for ovarian cancer with CA-125/ultrasound algorithm does not reduce mortality (UKCTOCS)
- Systematic review: lung cancer screening with CT decreases mortality but with significant harms
- Prostate cancer screening: no mortality benefit after 15 years of follow-up (PLCO)
- Low-dose CT screening decreases mortality in heavy smokers
- Lung cancer screening with low-dose CT does not affect smoking cessation rates
- Screening CA-125 and transvaginal ultrasound does not reduce ovarian cancer mortality
- Volume-based low-dose CT screening reduces lung cancer–specific mortality (NELSON)
- Prostate cancer screening: no mortality benefit after 13 years of follow-up (PLCO)
- Lung cancer screening may increase the likelihood of smoking cessation
- High false positive rate in repeated, multimodal screening for cancers (PLCO)
- CT finds early lung Ca but carries risk (PLuSS)
- Adherence to lung cancer screening is relatively poor after baseline scan
- Probability of cancer in high-risk patients with pulmonary nodules detected by low-dose screening CT
- PSA screening does not reduce mortality from prostate CA (PLCO)
Chemotherapy for non‐small cell lung cancer- PSA screening has marginal effect on mortality in European study (ERSPC)
- Ovarian cancer screening does not improve outcomes (UKCTOCS)
- PSA for screening of prostate cancer
- Impact of PSA screening on quality of life
- Screening for prostate cancer
- Systematic screening and assessment of psychosocial well‐being and care needs of people with cancer
- Flex sig reduces incidence and mortality of colorectal cancer
- Post-operative radiotherapy for ductal carcinoma in situ of the breast: Cochrane systematic review
- Alcoholic liver disease (ALD)
- Myositis
- Deep vein thrombosis
- Lymphomas
- Clinical, functional, and demographic factors predict 10-year mortality in adults older than 50
- Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
- Chemotherapy for advanced gastric cancer